Home > Research Institute > Available Trials > Screening Study to determine biomarker status for patients with malignant tumors
Screening Study to determine biomarker status for patients with malignant tumors
Master Screening Study to determine biomarker status and potential trial eligibility for patients with malignant tumors
Disease Types: Lung
Available at: Alleghany, Blacksburg, Roanoke, Salem, Wytheville
Master Screening Study to determine biomarker status and potential trial eligibility for patients with malignant tumors
For More Information: